Indobufen-based dual antiplatelet therapy in patients undergoing PCI: a systematic review and meta-analysis. [PDF]
Liu Y, Liu B, Dai W.
europepmc +1 more source
Platelet Reactivity and Sex Differences: Clinical Implications for Women. [PDF]
Aggarwal A +10 more
europepmc +1 more source
Personalized Antithrombotic Therapy After Percutaneous Coronary Intervention: A Systematic Review of Risk-Stratified Approaches. [PDF]
Kochkarian T +4 more
europepmc +1 more source
Antithrombotic Therapy in Primary and Secondary Prevention of Coronary Artery Disease. [PDF]
Di Leo G +4 more
europepmc +1 more source
Is Aspirin Still Indispensable After PCI-Rethinking Dual Antiplatelet Therapy in Contemporary Practice. [PDF]
Yadav K +6 more
europepmc +1 more source
Aspirin Withdrawal Before 30 Days After PCI in Acute Coronary Syndrome and Early Myocardial Infarction Risk: A Systematic Review and Meta-analysis. [PDF]
Murtafa KM +10 more
europepmc +1 more source
Percutaneous Coronary Interventions: Bleeding Risk Assessment and Management. [PDF]
Salihu A +7 more
europepmc +1 more source
Prasugrel 5 mg in acute coronary syndromes: indications and clinical outcomes. [PDF]
Tanajura LFL +4 more
europepmc +1 more source
An Uninterrupted DOAC plus Single Antiplatelet Strategy for Carotid Artery Stenting in Patients with Atrial Fibrillation. [PDF]
Suzuki K +5 more
europepmc +1 more source
Adjunctive Tirofiban is not Associated with Reduced 30-Day Ischemic Events in NSTE-ACS Patients with Complex Coronary Lesions After PCI: A Retrospective Observational Cohort Study. [PDF]
Sun R +8 more
europepmc +1 more source

